2 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 2 |
Follow Dosage Forms: new trials by email Literature Review of Dosage Forms trials Research Report on Dosage Forms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis TNFi (Tumor Necrosis Factor inhibitor) medication, Abatacept, Tocilizumab - Polyarticular Course Juvenile Idiopathic Arthritis (JIA) | Phase 3 | Recruiting | Duke University | 400 | 2026-01-09 | 2026-10-21 |
| Cellulitis Optimal Antibiotic Treatment Flucloxacillin Only Product in Oral Dose Form, Placebo Only Product in Oral Dose Form - Cellulitis of Leg | Phase 3 | Recruiting | University of Southampton | 334 | 2023-08-29 | 2026-05-15 |
Arthritis, Juvenile (1) · Pain (1)
Duke University (1) · University of Southampton (1)
Germany (1) · Italy (1) · Netherlands (1) · United Kingdom (1) · United States (1)